Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 6 days ago
44 views
Shared 2 weeks ago
177 views
Shared 3 weeks ago
340 views
Shared 1 month ago
477 views
Shared 2 months ago
449 views
Shared 2 months ago
456 views
Shared 2 months ago
106K views
Shared 3 months ago
350 views
Shared 3 months ago
335 views
Shared 3 months ago
210K views
Shared 4 months ago
286 views
Shared 6 months ago
473K views
Shared 6 months ago
204 views
Shared 6 months ago
85 views
Shared 7 months ago
537 views
Shared 7 months ago
1.4K views
Shared 8 months ago
405 views
Shared 9 months ago
566 views
Shared 10 months ago
107K views
Shared 10 months ago
150 views
Shared 10 months ago
41K views
Shared 10 months ago
342 views
Shared 10 months ago
103K views
Shared 1 year ago
787 views
Shared 1 year ago
164 views
Shared 1 year ago
456 views
Shared 1 year ago
18K views
Shared 1 year ago
23K views
Shared 1 year ago
345 views
Shared 1 year ago
700 views